舒利迭

舒利迭吸入剂对COPD患者缓解期治疗的疗效

Seretide inhalation in the treatment of COPD patients in remission period of clinical observation

舒利迭吸入对中重度COPD患者的疗效观察

Efficacy Observation on Inhalation Treatment with Seretide inhalation for Cases of Moderate and Severe COPD

均给予吸入沙美特罗/丙酸氟替卡松干粉剂（商品名：舒利迭，剂量：50μg/500μg）每日2次，疗程6个月。

All the patients inhaled salmeterol / fluticasone propionate dry powder ( seretide , 50 μ g500 μ g ) twice daily for six months .

结论中重度COPD缓解期患者使用天晴速乐及舒利迭联合吸入治疗可提高疗效，改善预后。

Conclusion The combination of Tiotropium and Scrctidc in patients with severe COPD can improve the efficacy .

目的了解应用舒利迭治疗煤工尘肺合并COPD的临床疗效。

Objective To understand the clinical curative effect of seretidc treatment of coal worker 's pneumoconiosis associated with COPD .

舒利迭组治疗前后血中CRP水平具有显著性差异（P0.05）。

The CRP levels in blood are significantly different ( P 0.05 ) in the seretide treatment groups before and after treatment .

舒利迭可以改善COPD患者肺通气功能、缓解症状、提高生活质量。

Seretide can improve patients with COPD lung ventilation function , to alleviate the symptoms , and improve the quality of life .

治疗前常规治疗组与舒利迭组血浆IL-8水平无显著性差异（P0.05）。

Before treatment , the IL-8 levels in blood are not significantly different ( P 0.05 ) between the seretide treatment groups and the conventional therapy group .

BiPAP通气联合舒利迭对COPD稳定期患者生活质量的影响分析

Analysis of the effect of BiPAP ventilation combined with seretide to the life quality of the patients with COPD in the stable period

结果3组COPD患者经治疗后临床症状、生活质量评分、肺功能、血气分析均有明显改善（P〈0.05），而天晴速乐及舒利迭联合治疗其改善作用更为显著（P〈0.05）。

Results Clinic symptom , life quality score , pulmonary function arterial blood gas were improved in all groups compare with those before treatment ( P0 · 05 ), especially in combination group ( P0 · 05 ) .

结果：32例中度哮喘患者舒利迭治疗4周后26例患者（81.3%）症状改善，症状与外周血中EOS数无关，而与外周血IL-4、IgE呈正相关，与肺功能呈负相关。

We observed the improvement of symptoms and the changes of these indexes , before and after Seretide treating 32 patients with moderate asthma for four weeks .

目的：研究舒利迭（沙美特罗/替卡松粉吸入剂，50μg/250μg）对中重度慢性阻塞性肺病（COPD）患者肺功能的影响。

Objective : To evaluate the effect of inhaled Seretide ( salmeterol 50 μ g and fluticasone propionate 250 μ g ) on lung function in patients with moderate-severe chronic obstructive pulmonary disease ( COPD ) .

结论舒利迭联合BiPAP治疗稳定期COPD病人能够明显改善其症状，提高生活质量，有一定的临床应用价值，对减缓COPD病人肺功能下降有积极意义。

Conclusion Treatment with seretide accuhaler combined with BiPAP in COPD can improve clinical symptoms and quality of life . It has certain value of clinical application , and it can step down the decrease of lung function in COPD patients .

舒利迭和顺尔宁联合应用对CODP肺功能的影响舒利迭吸入治疗慢性阻塞性肺病疗效评价

A study to assess the effects of combining seretide and singulair on patients with COPD Efficacy observation of seretide in treatment of COPD

在治疗后第8周，加用孟鲁司特组FEV1改善率和FEV1占预计值的百分数较舒利迭组的提高有显著差异（P<0·05）。

The improved rate of FEV1 and FEV1 % in the predicted value in the group plus montelukast was significantly higher than that in the group without montelukast at week 4 after treatment ( P < 0.05 ) .

目的探讨沙美特罗替卡松粉吸入剂（商品名舒利迭Seretide，葛兰素史克公司生产）治疗儿童哮喘的疗效及副作用。

Aim To study the curative effect and side effect of salmeterol and fluticasone propinate combined in a new powder inhalation device ( company 's product name is Seretide , GlaxoSmithKline campany produces ) on children asthma .

舒利迭联合顺尔宁治疗激素依赖型支气管哮喘临床分析

Treatment Effect of Salmeterol Combined with Singulair on Hormone-dependent Bronchial Asthma

舒利迭吸入治疗哮喘急性发作后55例疗效观察

Observation on Seretide in the treatment of 55 acute asthma attacked patients

舒利迭粉吸入剂对Ⅲ～Ⅳ级慢性阻塞性肺病患者肺功能的影响

Seretide Accuhaler on Lung Functions of COPD Patients in ⅲ - ⅳ stage

舒利迭吸入治疗儿童哮喘的效果

Therapeutic effect of seretide inhalation on children with asthma

小剂量舒利迭联合罗红霉素治疗支气管哮喘的临床疗效

Effect of low dose seretide with roxithromycin in the treatment of bronchial asthma

舒利迭治疗慢性阻塞性肺疾病缓解期疗效观察

Effect of seretide on stable chronic obstructive pulmonary diseases

目的探讨舒利迭治疗支气管哮喘的临床疗效。

Objective To investigate the clinical curative effect of seretide on bronchial asthma .

舒利迭吸入治疗慢性阻塞性肺病疗效评价

Efficacy observation of seretide in treatment of COPD

舒利迭在治疗慢性阻塞性肺病中的辅助作用

The Effect of Salmeterol Xinafoate and Fluticasone Propionate Powder for in Treating Chronic Obstructive Pulmonary Disease

舒利迭治疗哮喘急性发作的疗效

Effect of Inhalation of Salmeterol Xinafoate and Fluticasone Propionate Powder in Acute Onset of Children with Asthma

舒利迭治疗中重度儿童哮喘疗效观察与评价

Evaluated the Clinical Effects of Salmeterol / fluticasone Propionate Combination Therapy in Treating Moderate to Severe Pediatric Asthma

目的比较孟鲁司特与舒利迭联合治疗与单用舒利迭治疗重度哮喘的有效性。

Objective To compare the efficiency of seretide plus montelukast and seretide only on patients with severe persistent asthma .

结果舒利迭可以减少支气管哮喘病人急性发作次数和减轻发作时的症状，以致完全控制发作。

Results Seretide ould reduce the frequency of acute attack of asthma and alleviate symptom onset , so as to control onset completely .

吸入糖皮质激素、β2-兴奋剂、舒利迭能按用药剂量的依从性达80%以上者分别为37.1%、53.2%、75.5%。

The compliance with the prescribed doses of inhaled corticosteroids ,β _2-receptor agonist and Seretide were 37.1 % 、 53.2 % 、 75.5 % , respectively .